Thailand postpones vaccine after blood-clotting reports
The launch of the AstraZeneca vaccine had been postponed on friday by the The Ministry of Public Health as they are waiting results of a test after cases of blood clotting have been reported in some countries.
Dr Piyasakol Sakonsattayatorn, consultant on strategy and planning for management of the Covid-19 vaccine, announced
the postponement of AstraZeneca vaccination for Prime Minister Prayut Chan-o-cha and Cabinet members, who were to be the first recipients.
Dr Piyasakol stated that it is now a need to delay the vaccination after report from Denmark and Austria on Thursday regarding suspected side-effects that has been causing the blood to clot in veins.
The Ministry of Public Health and the medical team believed that the vaccination would be the safest for the public but wanted to find out if the side-effects in some European countries, especially Denmark and Austria, were caused by the vaccination, he said.
Prof Dr Yong Poovorawan, head of the Centre of Excellence in Clinical Virology at the Faculty of Medicine, Chulalongkorn University, in Bangkok said there were chances of finding adverse reactions or side-effects in a mass vaccination programme.
Blood clot in the veins is most common among African and European people, who are at three times more risk than Asians, indicating that genetic factors are involved.
There are currently 3 million doses of the vaccine given in Europe, of whom 22 have died, or 7 in a million.